Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Baker Hughes A | BKR | May 17, 2024 | 33.46 | +1.33 |
Ball | BALL | May 17, 2024 | 70.11 | -0.16 |
Bank Of America | BAC | May 17, 2024 | 39.29 | +0.18 |
Bank Of New York Mellon | BK | May 17, 2024 | 59.50 | +1.24 |
Bath & Body Works | BBWI | May 17, 2024 | 50.16 | +2.47 |
Baxter International | BAX | May 17, 2024 | 35.25 | +0.23 |
Becton, Dickinson And Co | BDX | May 17, 2024 | 236.30 | -0.14 |
Berkshire Hathaway B | BRK-B | May 17, 2024 | 416.94 | +0.92 |
Best Buy | BBY | May 17, 2024 | 73.35 | -0.39 |
Bio-Rad Laboratories A | BIO | May 17, 2024 | 293.85 | -0.64 |
Bio-Techne | TECH | May 17, 2024 | 83.81 | +1.16 |
Biogen | BIIB | May 17, 2024 | 230.57 | +0.23 |
BlackRock | BLK | May 17, 2024 | 812.22 | +0.56 |
Blackstone | BX | May 17, 2024 | 125.67 | -1.73 |
Boeing | BA | May 17, 2024 | 184.95 | +1.09 |
Booking | BKNG | May 17, 2024 | 3 708.35 | -0.71 |
BorgWarner | BWA | May 17, 2024 | 37.09 | -1.44 |
Boston Properties | BXP | May 17, 2024 | 63.20 | -0.71 |
Boston Scientific | BSX | May 17, 2024 | 74.65 | +0.13 |
Bristol-Myers Squibb | BMY | May 17, 2024 | 44.03 | -0.18 |
Broadcom | AVGO | May 17, 2024 | 1 395.29 | -1.19 |
Broadridge Financial Solutions | BR | May 17, 2024 | 203.49 | -0.26 |
Brown & Brown | BRO | May 17, 2024 | 89.83 | +0.48 |
Brown Forman B | BF-B | May 17, 2024 | 48.47 | -0.45 |
Builders Firstsource | BLDR | May 17, 2024 | 167.05 | +1.00 |
Bunge | BG | May 17, 2024 | 103.09 | -1.09 |
C.H. Robinson Worldwide | CHRW | May 17, 2024 | 84.11 | +1.15 |
Cadence Design Systems | CDNS | May 17, 2024 | 288.81 | -0.04 |
Caesars Entertainment | CZR | May 17, 2024 | 35.52 | +0.59 |
Camden Property Trust | CPT | May 17, 2024 | 106.50 | -0.02 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.